Famciclovir therapy for recurrent hepatitis B virus infection after liver transplantation
- 1 August 1996
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 9 (s1) , S210-S212
- https://doi.org/10.1111/j.1432-2277.1996.tb01611.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- PROSTAGLANDIN E PLUS FAMCICLOVIR—A NEW CONCEPT FOR THE TREATMENT OF SEVERE HEPATITIS B AFTER LIVER TRANSPLANTATION1,2Transplantation, 1994
- Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovoJournal of Medical Virology, 1994
- Liver Transplantation in European Patients with the Hepatitis B Surface AntigenNew England Journal of Medicine, 1993
- Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation.Gut, 1992
- Liver transplantation in HBs antigen (HBsAg) carriers: Prevention of hepatitis B virus (HBV) recurrence by passive immunizationJournal of Hepatology, 1991
- A cell culture assay for compounds which inhibit hepatitis B virus replicationAntiviral Research, 1991
- SEROLOGIC AND DNA FOLLOW-UP DATA FROM HBsAg-POSITIVE PATIENTS TREATED WITH ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1991
- Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]Antimicrobial Agents and Chemotherapy, 1989